Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC Serplulimab has now...

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product PALO ALTO, Calif., Feb. 5, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent...

ReTo Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

ReTo Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

BEIJING, Feb. 5, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a manufacturer of equipment for production of eco-friendly materials in China, today announced that the Company received a delisting...

LabConnect Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members

LabConnect Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members

JOHNSON CITY, Tenn., Feb. 4, 2025 /PRNewswire/ -- LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its...

Sirva Appoints Carlyn Taylor as Chief Executive Officer

Sirva Appoints Carlyn Taylor as Chief Executive Officer

OAKBROOK TERRACE, Ill., Feb. 4, 2025 /PRNewswire/ -- Sirva Worldwide, Inc. ("Sirva" or the "Company"), a leading global relocation and moving services provider, today announced the appointment of Carlyn Taylor as Chief Executive Officer and a member...

Four Seasons Education Receives Non-Compliance Letter from NYSE Regarding Holders Requirements

Four Seasons Education Receives Non-Compliance Letter from NYSE Regarding Holders Requirements

SHANGHAI, Feb. 3, 2025 /PRNewswire/ -- Four Seasons Education (Cayman) Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a tourism and education-related service provider in China, today announced that it has received a letter from the...

Axcelis Wins The 2024 SK hynix CSO Safety and Health Award

Axcelis Wins The 2024 SK hynix CSO Safety and Health Award

Award Recognizes Companies Who Achieve Highest Level of Safety BEVERLY, Mass., Feb. 3, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, has...

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from antibody engineering company ImaginAb, Inc....

Vectorworks Report Reveals the Technologies Transforming the AEC Industry in 2025 and Beyond

Vectorworks Report Reveals the Technologies Transforming the AEC Industry in 2025 and Beyond

New Report Shares What Industry Professionals Think About BIM, AI, AR, VR, and Sustainable Design Analysis. COLUMBIA, Md., Jan. 30, 2025 /PRNewswire/ -- Global design and BIM software provider Vectorworks, Inc. has released its latest report,...

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

Advanced Aesthetic Technologies, Inc. is pleased to announce the approval of Algeness® VL agarose facial injection filler for marketing in China

AAT announces additional significant updates RADNOR, Pa., Jan. 29, 2025 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. ("AAT") announced today that their partner in China has obtained approval to market their unique dermal filler Algeness® VL...

  • 1
  • ...
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • ...
  • 29
  • menu
    menu